Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RY14 | Q15391 | 5/20 | 0.52 |
| ▸ | QPCT | Q16769 | 3/20 | 0.49 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.47 |
| ▸ | NAMPT | P43490 | 2/20 | 0.47 |
| ▸ | ATM | Q13315 | 2/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | P2RY6 | Q15077 | 1/20 | 0.46 |
| ▸ | NPC1 | O15118 | 2/20 | 0.46 |
| ▸ | RAB9A | P51151 | 2/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 3/20 | 0.46 |
| ▸ | CASP3 | P42574 | 1/20 | 0.45 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.45 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.45 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11557199 | 0.83 | NAMPT (0.52) | P2RY14QPCTEPHX1KMT2ANAMPT | |
| SCHEMBL17036636 | 0.76 | ADRA2A (0.54) | QPCTEPHX1NAMPTHTT | |
| SCHEMBL11844716 | 0.76 | P2RY14 (0.54) | P2RY14QPCTEPHX1KMT2ANAMPT | |
| SCHEMBL29618001 | 0.75 | MEN1 (0.55) | KMT2ACYP3A4RAB9ASMN1; SMN2HTT | |
| SCHEMBL4422426 | 0.75 | IRAK4 (0.49) | KMT2ANPC1RAB9ASMN1; SMN2HTT | |
| SCHEMBL4422428 | 0.75 | IRAK4 (0.49) | KMT2ANPC1RAB9ASMN1; SMN2HTT | |
| SCHEMBL2545182 | 0.75 | EPHX1 (0.48) | P2RY14QPCTEPHX1NAMPTHTT | |
| SCHEMBL4811515 | 0.75 | P2RY14 (0.49) | P2RY14QPCTEPHX1KMT2ANAMPT | |
| SCHEMBL11830329 | 0.75 | P2RY14 (0.55) | P2RY14QPCTEPHX1KMT2ANAMPT | |
| SCHEMBL4811518 | 0.75 | P2RY14 (0.49) | P2RY14QPCTEPHX1KMT2ANAMPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220144775-A1 | HYDRAZIDE COMPOUND AND KINASE INHIBITOR | NISSAN CHEMICAL CORPORATION (JP) | 2022-05-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220144775-A1 | HYDRAZIDE COMPOUND AND KINASE INHIBITOR | LATS1, LATS2, STK4 | P2RY14 4375/4885QPCT 1583/4885EPHX1 2427/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.